US 9085577
7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
granted A61KA61K31/437A61K31/444
Quick answer
US patent 9085577 (7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors) held by Addex Pharma, S.A. expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Addex Pharma, S.A.
- Grant date
- Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/437, A61K31/444, A61K31/4545, A61K31/5377